Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Bone Marrow Transplantation|January 27, 2004
Chronic graft-versus-host disease: where do we go from here?S S FaragAnnals of Internal Medicine|March 15, 1992
Delay by internists in obtaining diagnostic biopsies in patients with suspected cancerS S Farag, M D Green, G Morstyn, et al.The Journal of Infection|September 1, 1992
Fatal disseminated Scedosporium inflatum infection in a neutropenic immunocompromised patientS S Farag, F C Firkin, J H Andrew, et al.Leukemia Research|December 18, 2007
Phase II clinical trial of arsenic trioxide with liposomal doxorubicin, vincristine, and dexamethasone in newly diagnosed multiple myelomaC C Hofmeister, B Jansak, N Denlinger, et al.Bone Marrow Transplantation|March 7, 2003
Radiation-free regimens result in similar outcomes of allogeneic hematopoietic progenitor cell transplantation in patients aged >or=50 years compared to younger adults with low-risk diseaseS S Farag, P J Elder, G Marcucci, et al.Bone Marrow Transplantation|February 16, 2005
High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemiaS S Farag, B J Bolwell, P J Elder, et al.Leukemia|January 22, 2011
Phase I trial and pharmacokinetic study of high-dose clofarabine and busulfan and allogeneic stem cell transplantation in adults with high-risk and refractory acute leukemiaS S Farag, L L Wood, J E Schwartz, et al.Bone Marrow Transplantation|January 12, 2010
Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasiaR P Nelson, M Yu, J E Schwartz, et al.Pageof 1